| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP And Chief Medical Officer
1 company
Smith Thomas B is an EVP And Chief Medical Officer at COLLEGIUM PHARMACEUTICAL, INC. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 29, 2025 | COLL Collegium Pharmaceutical, Inc | EVP And Chief Medical Officer | Sell | 17,478 | $38.42 | $671,576.42 | -19.9% | +20.3% | - | |
| Sep 13, 2024 | COLL Collegium Pharmaceutical, Inc | EVP And Chief Medical Officer | Sell | 9,593 | $36.62 | $351,319.64 | -15.1% | -19.8% | -0.5% | |
| Feb 29, 2024 | COLL Collegium Pharmaceutical, Inc | EVP And Chief Medical Officer | Sell | 995 | $36.76 | $36,580.18 | -1.5% | -9.6% | -20.9% |